June 18, 2024 03:49 PM EDT

International society criticizes Utah law for permitting unapproved stem cell therapies

Lia DeGroot

The International Society for Cell and Gene Therapy is pushing back against a Utah law that allows healthcare providers to treat patients with placental stem …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

International society criticizes Utah law for permitting unapproved stem cell therapies

Lia DeGroot

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Steve Davis leaves Acadia, replaced by Bristol Myers alum; Former J&J exec to lead R&D at Novavax

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry

WeightWatchers replaces CEO who spearheaded its push into prescription weight loss drugs

US government renews threats over J&J's proposed 340B rebate model

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

In­ter­na­tion­al so­ci­ety crit­i­cizes Utah law for per­mit­ting un­ap­proved stem cell ther­a­pies

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

International society criticizes Utah law for permitting unapproved stem cell therapies